Human Genome Epidemiology Literature Finder
|
Records 1 - 13 (of 13 Records) |
| Query Trace: Leukemia and KIR2DL2[original query] |
|---|
| Comparison of killer Ig-like receptor genotyping and phenotyping for selection of allogeneic blood stem cell donors. Journal of immunology (Baltimore, Md. : 1950) 2005 May 174 (10): 6540-5. Leung Wing, Iyengar Rekha, Triplett Brandon, Turner Victoria, Behm Frederick G, Holladay Marti S, Houston James, Handgretinger Rupe |
| [Distribution of immunoglobulin like receptor gene in Han population in China and the impact thereof on the HLA-identical sibling hematopoietic stem cell transplantation]. Zhonghua yi xue za zhi 2007 Nov 87 (44): 3111-4. Dou Li-Ping, DA Wan-Ming, Zhao Dan-Dan, Wang Chang, Lu Xue-Chun, Kang Hui-Yuan, Yan Pei, Wang Fei-Fei, Zhu Hai-Yan, Li Hong-Hua, Gao Chun-Ji, Yu |
| Inhibitory KIR/HLA incompatibility between sexual partners confers protection against HIV-1 transmission. Blood 2013 Feb 121 (7): 1157-64. Jennes Wim, Verheyden Sonja, Mertens Julie W, Camara Makhtar, Seydi Moussa, Dieye Tandakha N, Mboup Souleymane, Demanet Christian, Kestens L |
| Homozygosity for killer immunoglobin-like receptor haplotype A predicts complete molecular response to treatment with tyrosine kinase inhibitors in chronic myeloid leukemia patients. Experimental hematology 2013 Feb . La Nasa G, Caocci G, Littera R, Atzeni S, Vacca A, Mulas O, Langiu M, Greco M, Orrù S, Orrù N, Floris A, Carcassi C |
| Donor Haplotype B of NK KIR Receptor Reduces the Relapse Risk in HLA-Identical Sibling Hematopoietic Stem Cell Transplantation of AML Patients. Frontiers in immunology 2014 5 405. Impola Ulla, Turpeinen Hannu, Alakulppi Noora, Linjama Tiina, Volin Liisa, Niittyvuopio Riitta, Partanen Jukka, Koskela Sa |
| KIR and HLA genotypes predictive of low-affinity interactions are associated with lower relapse in autologous hematopoietic cell transplantation for acute myeloid leukemia. Journal of immunology (Baltimore, Md. : 1950) 2015 May 194 (9): 4222-30. Marra John, Greene Justin, Hwang Jimmy, Du Juan, Damon Lloyd, Martin Tom, Venstrom Jeffrey |
| KIR repertory in patients with hematopoietic diseases and healthy family members. BMC hematology 2016 16 25. Sugioka Daniele Kazue, Gonçalves Carlos Eduardo Ibaldo, Bicalho Maria da Gra |
| Prognostic role of KIR genes and HLA-C after hematopoietic stem cell transplantation in a patient cohort with acute myeloid leukemia from a consanguineous community. Bone marrow transplantation 2018 3 53 (9): 1170-1179. Gaafar Ameera, Sheereen Atia, Almohareb Fahad, Eldali Abdelmoneim, Chaudhri Naeem, Mohamed Said Y, Hanbali Amr, Shaheen Marwan, Alfraih Feras, El Fakih Riad, Iqneibi Alia, Youniss Riad, Elhassan Tusneem, Hashmi Shahrukh, Aljurf Mahmud, Alhussein Khal |
| Certain Killer Immunoglobulin-Like Receptor (KIR)/KIR HLA Class I Ligand Genotypes Influence Natural Killer Antitumor Activity in Myelogenous Leukemia but Not in Acute Lymphoblastic Leukemia: A Case Control Leukemia Association Study. Turkish journal of haematology : official journal of Turkish Society of Haematology 2019 Jul . Varbanova Viktoria Plamenova, Mihailova Snejina, Naumova Elissaveta, Mihaylova Anastasiya Petro |
| Following Transplantation for Acute Myelogenous Leukemia, Donor KIR Cen B02 Better Protects against Relapse than KIR Cen B01. Journal of immunology (Baltimore, Md. : 1950) 2021 6 206 (12): 3064-3072. Guethlein Lisbeth A, Beyzaie Niassan, Nemat-Gorgani Neda, Wang Tao, Ramesh Vidhyalakshmi, Marin Wesley M, Hollenbach Jill A, Schetelig Johannes, Spellman Stephen R, Marsh Steven G E, Cooley Sarah, Weisdorf Daniel J, Norman Paul J, Miller Jeffrey S, Parham Pet |
| Association of killer cell immunoglobulin-like receptors and their cognate HLA class I ligands with susceptibility to acute myeloid leukemia in Iranian patients. Scientific reports 2023 7 13 (1): 11456. Sara Mirzazadeh, Peyman Bemani, Hossein Halimi, Mohammad Nabi Sanaee, Narges Karami, Mani Ramzi, Shirin Farjadi |
| Combined flow cytometry natural killer immunophenotyping and KIR/HLA-C genotyping reveal remarkable differences in acute myeloid leukemia patients, but suggest an overall impairment of the natural killer response. Frontiers in medicine 2023 3 10 1148748. Cianga Vlad Andrei, Rusu Cristina, Pavel-Tanasa Mariana, Dascalescu Angela, Danaila Catalin, Harnau Sebastian, Aanei Carmen-Mariana, Cianga Pet |
| Activating KIR/HLA-I combinations as a risk factor of adult B-ALL. Human immunology 2024 1 110750. Hossein Halimi, Sara Mirzazadeh, Kurosh Kalantar, Maryam Hajimaghsoodi, Mani Ramzi, Shirin Farjadi |
- Page last reviewed:Feb 1, 2024
- Content source: